Literature DB >> 25214159

Adverse drug reactions reporting: pharmacists' knowledge, attitude and practice in Shiraz, Iran.

Saba Afifi1, Najmeh Maharloui1, Payam Peymani1, Soha Namazi2, Alireza Gholami Gharaei3, Pegah Jahani4, Kamran B Lankarani1.   

Abstract

BACKGROUND: While yellow card reporting system has started in 1998 in Iran, the ADR reporting rate is very low.
OBJECTIVE: In order to explore whether the Iranian Pharmacovigilance system could be modified, and to determine reasons for under-reporting, a study to investigate the role of pharmacists in ADR reporting was done in Shiraz.
METHODS: A cross-sectional study was conducted between January and June 2013 in Shiraz, Iran. After describing the study and its goal for each participant, oral consent was taken.
RESULTS: 100 out of 120 pharmacists (83.3%) agreed to participate in the interview. 79 out of 100 respondents were working in private pharmacies, 7% in governmental pharmacies, and 3% in pharmacies located in hospitals. Although level of knowledge regarding ADR was low among pharmacists, all of them admitted that paying attention to ADRs and timely reporting is very important. While 6 (6%) pharmacists thought that they had been taught too much about ADR in the university, 30% believed that it was enough, 41% claimed that it was not satisfactory and 23% admitted that it was little.
CONCLUSIONS: Our pharmacists have little knowledge about the process, goal, and importance of ADR spontaneous reporting system. Otherwise, education and training courses will be important in maintaining, improving and enhancing ADR reports by pharmacists.

Entities:  

Keywords:  Iran; Pharmacists; attitude; knowledge; practice adverse drug reaction reporting

Mesh:

Year:  2014        PMID: 25214159     DOI: 10.3233/JRS-140620

Source DB:  PubMed          Journal:  Int J Risk Saf Med        ISSN: 0924-6479


  6 in total

1.  Knowledge of Adverse Drug Reaction Reporting Among Healthcare Professionals in Bhutan: A Cross-Sectional Survey.

Authors:  Choki Dorji; Pramote Tragulpiankit; Arthorn Riewpaiboon; Tashi Tobgay
Journal:  Drug Saf       Date:  2016-12       Impact factor: 5.606

2.  An Exploration of the Protective Effects of Investigators' Ethical Awareness upon Subjects of Drug Clinical Trials in China.

Authors:  L Zhang; X X Huang; H F Chen
Journal:  J Bioeth Inq       Date:  2017-12-11       Impact factor: 1.352

3.  The Pattern of Medication Usage in the Southern Region of Iran: A population-based Pharmacoepidemiological Study.

Authors:  Marziyeh Zare; Saba Afifi; Amir Hossein Alizadeh Bahmani; Iman Karimzadeh; Mohammad Salehi-Marzijarani; Leila Zarei; Behnam Honarvar; Sulmaz Ghahremani; Kamran B Lankarani; Ali Mohammad Sabzghabaee; Payam Peymani
Journal:  J Res Pharm Pract       Date:  2021-08-03

4.  Evaluating Pharmacist's Patient Care Process in Shiraz, using a newly-validated questionnaire: The First Report from Iran.

Authors:  Marziyeh Zare; Leila Zarei; Saba Afifi; Iman Karimzadeh; Mustafa Ghaeminia; Farzad Peiravian; Mohammad Salehi-Marzijarani; Kamran B Lankarani; Payam Peymani
Journal:  Acta Biomed       Date:  2020-09-07

5.  Knowledge, attitude and practices of pharmacovigilance and adverse drug reaction reporting among pharmacists working in secondary and tertiary governmental hospitals in Kuwait.

Authors:  Fatemah M Alsaleh; Sherifah W Alzaid; Eman A Abahussain; Tania Bayoud; Jacinthe Lemay
Journal:  Saudi Pharm J       Date:  2016-12-26       Impact factor: 4.330

6.  Assessing knowledge, attitude, and practices of health-care providers toward pharmacovigilance and adverse drug reaction reporting at a comprehensive cancer center in Jordan.

Authors:  Abeer Ahmad Al Rabayah; Esra'a Mahmoud Hanoun; Ruba Hab Al Rumman
Journal:  Perspect Clin Res       Date:  2019 Jul-Sep
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.